Health
New clinical trial shows combination of two innovative precision medicines could treat multiple cancers – News-Medical.Net
Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical trial shows.
Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical trial shows.
It is the first trial to use the pioneering genetically targeted drug olaparib – already licensed for ovarian, breast and prostate cancer – together with a promising new medicine, called capivasertib.
The researchers used the drug combination to target two fundamental weaknesses in cancer at the same time – a damaged…
-
General13 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News20 hours agoPrime Minister Anthony Albanese calls for political temperature to be ‘turned down’ after alleged death threat
-
Noosa News19 hours agoYork family honours late son with tractor museum to fund cancer research
-
Noosa News21 hours agoRoosters forward Aliyah Nasio sent to judiciary over NRLW grand final brawl